Pharmacological Effects and Molecular Protective Mechanisms of Astragalus Polysaccharides on Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) has been renamed metabolic dysfunction-associated fatty liver disease (MAFLD), a condition for which there is now no authorized treatment. The search for new medications to treat MAFLD made from natural substances is gaining traction. The function of anti-oxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jing, Feng, Quansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929346/
https://www.ncbi.nlm.nih.gov/pubmed/35308224
http://dx.doi.org/10.3389/fphar.2022.854674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929346/
https://www.ncbi.nlm.nih.gov/pubmed/35308224
http://dx.doi.org/10.3389/fphar.2022.854674

Ejemplares similares